Webster Bank N. A. Sells 650 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Webster Bank N. A. lessened its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 9.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 6,414 shares of the financial services provider’s stock after selling 650 shares during the period. Webster Bank N. A.’s holdings in iShares Biotechnology ETF were worth $848,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of IBB. Hsbc Holdings PLC boosted its position in shares of iShares Biotechnology ETF by 47.1% during the 2nd quarter. Hsbc Holdings PLC now owns 3,670 shares of the financial services provider’s stock valued at $504,000 after acquiring an additional 1,175 shares during the last quarter. Bank of Montreal Can lifted its position in iShares Biotechnology ETF by 2.6% during the second quarter. Bank of Montreal Can now owns 36,198 shares of the financial services provider’s stock valued at $5,086,000 after purchasing an additional 920 shares during the last quarter. Creative Planning grew its stake in iShares Biotechnology ETF by 2.9% in the 2nd quarter. Creative Planning now owns 67,902 shares of the financial services provider’s stock worth $9,320,000 after buying an additional 1,905 shares in the last quarter. NewEdge Advisors LLC grew its stake in iShares Biotechnology ETF by 20.1% in the 2nd quarter. NewEdge Advisors LLC now owns 11,633 shares of the financial services provider’s stock worth $1,597,000 after buying an additional 1,944 shares in the last quarter. Finally, B. Riley Wealth Advisors Inc. increased its holdings in shares of iShares Biotechnology ETF by 2.0% in the 2nd quarter. B. Riley Wealth Advisors Inc. now owns 11,722 shares of the financial services provider’s stock worth $1,609,000 after buying an additional 229 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.7 %

NASDAQ IBB opened at $137.30 on Monday. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57. The company has a fifty day moving average of $136.04 and a 200-day moving average of $141.81.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.